Fecal microbiota transplants (FMTs) have recently been introduced into cancer therapy as a way to make treatment-resistant melanoma patients responsive again to immune checkpoint inhibitors (ICIs). Congratulations to Spakowicz Lab on this publication in the latest issue of Cell Host & Microbe!